Software - Infrastructure
Compare Stocks
4 / 10Stock Comparison
MSAI vs AEYE vs ALKT vs SGHT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Medical - Devices
MSAI vs AEYE vs ALKT vs SGHT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Application | Software - Application | Medical - Devices |
| Market Cap | $5M | $100M | $1.87B | $286M |
| Revenue (TTM) | $6M | $40M | $472M | $80M |
| Net Income (TTM) | $-12M | $-3M | $-50M | $-37M |
| Gross Margin | 19.9% | 78.3% | 57.4% | 86.2% |
| Operating Margin | -217.0% | -7.9% | -9.3% | -44.8% |
| Forward P/E | — | — | 21.7x | — |
| Total Debt | $0.00 | $721K | $354M | $41M |
| Cash & Equiv. | $24M | $5M | $63M | $92M |
MSAI vs AEYE vs ALKT vs SGHT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| MultiSensor AI Hold… (MSAI) | 100 | 1.5 | -98.5% |
| AudioEye, Inc. (AEYE) | 100 | 104.4 | +4.4% |
| Alkami Technology, … (ALKT) | 100 | 60.8 | -39.2% |
| Sight Sciences, Inc. (SGHT) | 100 | 25.3 | -74.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MSAI vs AEYE vs ALKT vs SGHT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MSAI is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 1.69
- Beta 1.69, current ratio 11.66x
AEYE is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 102.2% 10Y total return vs ALKT's -59.5%
- -7.6% margin vs MSAI's -211.0%
ALKT carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 32.9%, EPS growth -12.2%, 3Y rev CAGR 29.5%
- Lower volatility, beta 1.30, Low D/E 97.7%, current ratio 2.09x
- 32.9% revenue growth vs MSAI's -25.0%
- Beta 1.30 vs SGHT's 2.49
SGHT is the clearest fit if your priority is momentum.
- +85.0% vs MSAI's -82.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.9% revenue growth vs MSAI's -25.0% | |
| Quality / Margins | -7.6% margin vs MSAI's -211.0% | |
| Stability / Safety | Beta 1.30 vs SGHT's 2.49 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +85.0% vs MSAI's -82.7% | |
| Efficiency (ROA) | -5.9% ROA vs MSAI's -59.8%, ROIC -8.6% vs -113.6% |
MSAI vs AEYE vs ALKT vs SGHT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MSAI vs AEYE vs ALKT vs SGHT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALKT leads in 2 of 6 categories
MSAI leads 1 • AEYE leads 0 • SGHT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — AEYE and ALKT each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALKT is the larger business by revenue, generating $472M annually — 85.0x MSAI's $6M. Profitability is closely matched — net margins range from -7.6% (AEYE) to -2.1% (MSAI). On growth, ALKT holds the edge at +28.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $6M | $40M | $472M | $80M |
| EBITDAEarnings before interest/tax | -$11M | -$504,000 | -$12M | -$35M |
| Net IncomeAfter-tax profit | -$12M | -$3M | -$50M | -$37M |
| Free Cash FlowCash after capex | -$10M | $2M | $44M | -$25M |
| Gross MarginGross profit ÷ Revenue | +19.9% | +78.3% | +57.4% | +86.2% |
| Operating MarginEBIT ÷ Revenue | -2.2% | -7.9% | -9.3% | -44.8% |
| Net MarginNet income ÷ Revenue | -2.1% | -7.6% | -10.6% | -46.8% |
| FCF MarginFCF ÷ Revenue | -173.9% | +5.5% | +9.4% | -31.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.9% | +7.9% | +28.9% | +12.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +66.8% | +29.0% | -22.7% | +14.3% |
Valuation Metrics
MSAI leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $5M | $100M | $1.9B | $286M |
| Enterprise ValueMkt cap + debt − cash | -$19M | $96M | $2.2B | $235M |
| Trailing P/EPrice ÷ TTM EPS | -0.47x | -32.36x | -37.89x | -7.15x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 21.69x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.97x | 2.49x | 4.20x | 3.69x |
| Price / BookPrice ÷ Book value/share | 0.17x | 20.91x | 5.00x | 4.31x |
| Price / FCFMarket cap ÷ FCF | — | — | 45.09x | — |
Profitability & Efficiency
ALKT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ALKT delivers a -14.0% return on equity — every $100 of shareholder capital generates $-14 in annual profit, vs $-74 for MSAI. AEYE carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALKT's 0.98x. On the Piotroski fundamental quality scale (0–9), SGHT scores 5/9 vs ALKT's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -74.4% | -47.8% | -14.0% | -59.1% |
| ROA (TTM)Return on assets | -59.8% | -9.5% | -5.9% | -32.2% |
| ROICReturn on invested capital | -113.6% | -42.4% | -8.6% | -2.7% |
| ROCEReturn on capital employed | -53.2% | -17.7% | -9.3% | -32.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 3 | 5 |
| Debt / EquityFinancial leverage | — | 0.15x | 0.98x | 0.64x |
| Net DebtTotal debt minus cash | -$24M | -$5M | $290M | -$51M |
| Cash & Equiv.Liquid assets | $24M | $5M | $63M | $92M |
| Total DebtShort + long-term debt | $0 | $721,000 | $354M | $41M |
| Interest CoverageEBIT ÷ Interest expense | -156.42x | -2.79x | -3.73x | -14.04x |
Total Returns (Dividends Reinvested)
ALKT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALKT five years ago would be worth $4,510 today (with dividends reinvested), compared to $147 for MSAI. Over the past 12 months, SGHT leads with a +85.0% total return vs MSAI's -82.7%. The 3-year compound annual growth rate (CAGR) favors ALKT at 12.2% vs MSAI's -76.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -53.2% | -18.7% | -23.1% | -29.3% |
| 1-Year ReturnPast 12 months | -82.7% | -27.9% | -37.8% | +85.0% |
| 3-Year ReturnCumulative with dividends | -98.6% | +20.6% | +41.1% | -49.7% |
| 5-Year ReturnCumulative with dividends | -98.5% | -60.2% | -54.9% | -84.2% |
| 10-Year ReturnCumulative with dividends | -98.5% | +102.2% | -59.5% | -84.2% |
| CAGR (3Y)Annualised 3-year return | -76.0% | +6.4% | +12.2% | -20.5% |
Risk & Volatility
Evenly matched — ALKT and SGHT each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALKT is the less volatile stock with a 1.30 beta — it tends to amplify market swings less than SGHT's 2.49 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SGHT currently trades 57.3% from its 52-week high vs MSAI's 6.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.69x | 2.29x | 1.30x | 2.49x |
| 52-Week HighHighest price in past year | $96.00 | $16.39 | $31.66 | $9.24 |
| 52-Week LowLowest price in past year | $0.33 | $5.31 | $14.11 | $2.81 |
| % of 52W HighCurrent price vs 52-week peak | +6.0% | +49.4% | +55.1% | +57.3% |
| RSI (14)Momentum oscillator 0–100 | 40.6 | 61.3 | 50.9 | 54.2 |
| Avg Volume (50D)Average daily shares traded | 45K | 194K | 1.9M | 357K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: MSAI as "Buy", ALKT as "Buy", SGHT as "Buy". Consensus price targets imply 82.8% upside for SGHT (target: $10) vs 26.2% for ALKT (target: $22).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $22.00 | $9.67 |
| # AnalystsCovering analysts | 1 | — | 12 | 9 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
ALKT leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). MSAI leads in 1 (Valuation Metrics). 2 tied.
MSAI vs AEYE vs ALKT vs SGHT: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is MSAI or AEYE or ALKT or SGHT a better buy right now?
For growth investors, Alkami Technology, Inc.
(ALKT) is the stronger pick with 32. 9% revenue growth year-over-year, versus -25. 0% for MultiSensor AI Holdings, Inc. (MSAI). Analysts rate MultiSensor AI Holdings, Inc. (MSAI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MSAI or AEYE or ALKT or SGHT?
Over the past 5 years, Alkami Technology, Inc.
(ALKT) delivered a total return of -54. 9%, compared to -98. 5% for MultiSensor AI Holdings, Inc. (MSAI). Over 10 years, the gap is even starker: AEYE returned +102. 2% versus MSAI's -98. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MSAI or AEYE or ALKT or SGHT?
By beta (market sensitivity over 5 years), Alkami Technology, Inc.
(ALKT) is the lower-risk stock at 1. 30β versus Sight Sciences, Inc. 's 2. 49β — meaning SGHT is approximately 91% more volatile than ALKT relative to the S&P 500. On balance sheet safety, AudioEye, Inc. (AEYE) carries a lower debt/equity ratio of 15% versus 98% for Alkami Technology, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — MSAI or AEYE or ALKT or SGHT?
By revenue growth (latest reported year), Alkami Technology, Inc.
(ALKT) is pulling ahead at 32. 9% versus -25. 0% for MultiSensor AI Holdings, Inc. (MSAI). On earnings-per-share growth, the picture is similar: MultiSensor AI Holdings, Inc. grew EPS 71. 0% year-over-year, compared to -12. 2% for Alkami Technology, Inc.. Over a 3-year CAGR, ALKT leads at 29. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MSAI or AEYE or ALKT or SGHT?
AudioEye, Inc.
(AEYE) is the more profitable company, earning -7. 6% net margin versus -211. 0% for MultiSensor AI Holdings, Inc. — meaning it keeps -7. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AEYE leads at -7. 9% versus -217. 0% for MSAI. At the gross margin level — before operating expenses — SGHT leads at 86. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is MSAI or AEYE or ALKT or SGHT more undervalued right now?
Analyst consensus price targets imply the most upside for SGHT: 82.
8% to $9. 67.
07Which pays a better dividend — MSAI or AEYE or ALKT or SGHT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is MSAI or AEYE or ALKT or SGHT better for a retirement portfolio?
For long-horizon retirement investors, Alkami Technology, Inc.
(ALKT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Sight Sciences, Inc. (SGHT) carries a higher beta of 2. 49 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALKT: -59. 5%, SGHT: -84. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MSAI and AEYE and ALKT and SGHT?
These companies operate in different sectors (MSAI (Technology) and AEYE (Technology) and ALKT (Technology) and SGHT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MSAI is a small-cap quality compounder stock; AEYE is a small-cap quality compounder stock; ALKT is a small-cap high-growth stock; SGHT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.